L'Eco di Bergamo, Economy - 16 May 2024

Q1 2024 closed with consolidated revenue of € 65.6 million, in line with the January-March period of 2023 - a record quarter due to an exceptional turnover increase.

Fine Foods & Pharmaceuticals N.T.M. S.p.A. CEO Giorgio Ferraris said: "Q1 2024, with its revenue in line with Q1 2023, showed a double-digit growth in Ebitda and increasing margins. This highlighted a reliable organisational management."

The financial well-being of the company is reflected in the increased bonus given to employees this year, included in the May salary, which was gross € 1,727, a significant rise from the previous year's gross bonus of approximately € 820. Consolidated revenue for 2023 was € 251.8 million, up 21.7% compared to € 206.9 million in 2022, and EBITDA 2023 saw a +44.5% increase to € 22.3 million from € 15.4 million in 2022.

The year 2023 was remarkable, with Fine Foods achieving a double-digit growth. The group's average growth over the past 10 years was 11 per cent against reference markets which grew at around five per cent: Ferraris said: "The market is recognising our efforts."

The Group received 11,350 CVs in 2023, confirming Fine Foods as an attractive place to work.

Read more in Giorgio Ferraris' interview with L'Eco di Bergamo.